Tempest Therapeutics Inc Cash Flow-to-Debt Ratio
Tempest Therapeutics Inc cash flow-to-debt ratio. Tempest Therapeutics Inc (TPST) has a Cash Flow-to-Debt Ratio of -0.26x as of June 2026, meaning its operating cash flow of $-2.78 Million could theoretically repay 0% of its total liabilities ($10.72 Million) in one year. See TPST free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tempest Therapeutics Inc (2012–2025)
Cash flow-to-debt ratio of Tempest Therapeutics Inc from 2012 to 2025. Historical debt coverage capacity for Tempest Therapeutics Inc across 14 annual periods. Check Tempest Therapeutics Inc (TPST) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Tempest Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Tempest Therapeutics Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Tempest Therapeutics Inc. For the full cash flow conversion analysis, see Tempest Therapeutics Inc cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.61x | $-26.82 Million | $10.26 Million | ▼ -76.9% |
| 2024 | -1.48x | $-33.03 Million | $22.36 Million | ▼ -34.1% |
| 2023 | -1.10x | $-27.36 Million | $24.84 Million | ▲ +0.8% |
| 2022 | -1.11x | $-31.07 Million | $27.98 Million | ▼ -58.8% |
| 2021 | -0.70x | $-25.96 Million | $37.12 Million | ▼ -237.0% |
| 2020 | -0.21x | $-19.02 Million | $91.66 Million | ▲ +92.4% |
| 2019 | -2.73x | $-41.22 Million | $15.10 Million | ▼ -26.4% |
| 2018 | -2.16x | $-23.65 Million | $10.95 Million | ▲ +48.7% |
| 2017 | -4.21x | $-20.34 Million | $4.83 Million | ▲ +2.3% |
| 2016 | -4.31x | $-61.73 Million | $14.32 Million | ▼ -0.8% |
| 2015 | -4.27x | $-50.29 Million | $11.76 Million | ▼ -43.2% |
| 2014 | -2.99x | $-30.59 Million | $10.25 Million | ▲ +3.6% |
| 2013 | -3.10x | $-18.09 Million | $5.84 Million | ▲ +41.9% |
| 2012 | -5.33x | $-11.16 Million | $2.09 Million | — |